R in regulated environments [🇷 for BE/BA]

posted by Achievwin – US, 2020-01-27 21:21 (1105 d 05:43 ago) – Posting: # 21088
Views: 3,626

I heard the same question during the BE-GBH meeting in Bethesda (and had a coffee Helmut). The short and sweet answer was you can submit your analysis whatever the software you are comfortable FDA runs their own analysis using internal tools, in the event the results differs by what magnitude is subjective) it triggers a review question.

Having said that I agree with the original post we need to do some kind of qualification, simple example is to do a cross comparison between R analysis and SAS/WinNonlin analysis (even better a 3 way comparison) This strategy worked in the past. It is better to have some validation than having no validation.

Regards,

Achievwin

Complete thread:

UA Flag
Activity
 Admin contact
22,479 posts in 4,709 threads, 1,603 registered users;
19 visitors (0 registered, 19 guests [including 9 identified bots]).
Forum time: 03:05 CET (Europe/Vienna)

The rise of biometry in this 20th century,
like that of geometry in the 3rd century before Christ,
seems to mark out one of the great ages or critical periods
in the advance of the human understanding.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5